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Abstract
The tissue expansion process is done after mastectomies to increase the submuscular space in preparation for the placement
of permanent breast implant. The process is often believed to be painful by patients who are often intimidated by the
prospect of mechanically stretching out their skin and muscle. This study aims to quantify the pain experienced by patients
and determine the different pain management techniques used. We used a case series approach, in which patients who were
undergoing serial tissue expansion process were asked to rate their pain and anxiety on a scale from 1 to 10, using a
questionnaire and the visual analog scale. Pain was rated during and after the expansion procedure, and patients were also
surveyed to find the most commonly used and most effective pain management technique. Patients typically reported very
little pain during and after the procedure, with an average of 0.4 to 2.5 pain experienced out of 10. The pain did not last, on
average, longer than 1 day. Furthermore, the most widely used and most helpful pain medication was ibuprofen. During the
tissue expansion procedure, the mean anxiety level was 0.64 (1.3). The findings show that tissue expansion process is a
relatively low pain procedure and is not a contraindication for undergoing breast reconstruction. Ibuprofen, a mild treatment
with few side effects, was efficacious in pain relief though most patients required no pain relief.
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Introduction
Breast cancer, the most prevalent cancer, affects over 230 000
women in the United States, on a yearly basis. 1 With
increased rates of women undergoing mastectomies, breast
reconstruction with tissue expansion has become a common
surgical procedure.2 This technique, pioneered by Radovan
and Argenta, involves the use of temporary, textured, or
smooth tissue expanders placed submuscularly, to gradually
expand the overlying skin and muscle.3,4 Weekly or biweekly
injections into the integrated-valve expander are given with
normal saline over a time period of several weeks to months
until a size slightly larger than target size is achieved or until
the patient is satisfied with her size.5 This allows for the
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eventual placement of a permanent implant into a soft reconstructed breast.6
Patients reported great satisfaction with the results of the
tissue expansion.7 However, some patients undergoing mastectomies may still have reservations about the tissue expansion
process due to the perceived high levels of pain. During this
process, it has been reported that patients can experience soreness, tightness, pain, and muscle spasms but not much is known
about the true pain levels.8
Currently, there is no gold standard for pain management
during the tissue expansion process, with a wide variety of
analgesic techniques available and commonly used.9 Some
methods, like massaging and breathing exercises during
injections, can help minimize the pain.10 Other treatment
modalities used include narcotic analgesia, nonsteroidal
anti-inflammatory drugs (NSAIDs), acetaminophen, local
anesthesia, regional anesthesia, muscle relaxants, and topical
anesthetics like EMLA.11,12 Several of these techniques may be
potentially addictive (ie, opioid-based regimens) and/or given
through an inconvenient intravenous route. Therefore, milder
methods of pain management should be explored to mitigate
any potential negative effects on patients.
In this study, we aim to elucidate the pain levels experienced
by patients during and after the tissue expansion. We also wish
to ascertain the pain management techniques most used and
most helpful for patients during the expansion process.

Methods
We performed a case series analysis and the study was
approved by the institutional review board (no. Pro00018026)
at the University of South Florida. All consecutive adult
patients who underwent tissue expansion after a mastectomy
performed by a single plastic surgeon between September and
November 2016 were eligible for inclusion. All surgeries and
tissue expansions were completed at H. Lee Moffitt Cancer
Center using the anatomical shape, integrated port, textured
tissue expander. All patients began the tissue expansion process
4 weeks after their reconstruction surgery. The tissue expanders
were placed during the reconstruction surgery. The 4-week gap
allows for moderate time to heal postsurgery and ensures that
the assessed pain levels are solely due to the tissue expansion
process. The tissue expansion process was completed prior to
radiation therapy.
All tissue expanders were placed in a total submuscular
plane. The technique used included an incision along the lateral
border of the pectoralis major muscle to create a submuscular
pocket under the pectoralis major muscle without the use of an
acellular dermal matrix. The serratus anterior fascia was elevated to allow for additional lateral coverage. The 3-0 Vicryl
was used to approximate the lateral border of the pectoralis
major muscle.
Data were collected on the number of tissue expansion sessions, volume of the tissue expander filled at each session, total
fill of the tissue expanders in cubic centimeter, anxiety level
prior to the procedure, pain experienced during the needle
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Figure 1. The mean pain levels at different time points during the
tissue expansion process.

injection, the pain during the expansion and after going home,
number of hours after the injections that the pain started,
number of days the pain lasted for, interventions for pain management, and the intervention most helpful during pain management. The anxiety level was assessed using a questionnaire
and pain levels during and after the procedure were assessed
using the visual analog scale. The volumes of the tissue expanders were measured based on the amount of saline that was
injected in graduated syringes.

Statistical Analysis
All outcomes were summarized using descriptive statistics
where continuous data were reported as mean/median along
with standard deviations (SDs) and binary data as proportions.
The unit of analysis for all outcomes was tissue expansion
procedures instead of patients. All analyses were performed
using SPSS v22 statistical analysis software.

Results
A total of 24 patients who met the inclusion criteria underwent
a total of 68 tissue expansion procedures. The mean number of
tissue expansion per patient was 4.4 (3), that is n ¼ 67 procedures, to reach their target size. The mean amount of saline
injected (in cubic centimeter) into the tissue expander was 81
(25), n ¼ 63 procedures, to reach a total of 432 (229) cubic
centimeter, n ¼ 63 procedures, by the end of the entire process.
During the tissue expansion procedure (n ¼ 64 procedures), the
mean anxiety level was 0.64 (1.3). As shown in Figure 1, the mean
level of pain due to the needle puncture was 0.4 (0.5), n ¼ 63
procedures. The mean pain level during the expansion was a 0.4
(1.5), n ¼ 62 procedures, while the mean pain level after going home
was 2.5 (3), n ¼ 55 procedures. The pain generally started, on
average, 4.2 (10.6) hours, n ¼ 55 procedures, hours after the procedure and lasted for a mean of 22.8 (38.4) hours, n ¼ 54 procedures.

Pain Management Interventions
As shown in Figure 2, 52% of the time (n ¼ 54 procedures),
patients did not require any intervention for pain management.
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Figure 2. Different pain management options used by patients during the tissue expansion process.

The most common intervention for pain management was ibuprofen alone (22%), followed by ibuprofen in combination with
acetaminophen (5.6%), muscle relaxant (3.7%), or ice (3.7%);
5.6% of cases used compound cream. Use of opioid either
alone or in combination with ice, acetaminophen, or ibuprofen
was restricted to 1.9% of cases. As shown in Figure 3, 50% of
the time, patients did not require any medications for pain
management. Ibuprofen alone was found to be helpful after
27.8% of the procedures. Ibuprofen in combination with ice
was reported to be helpful after 5.6% of the procedures followed by ibuprofen in combination with muscle relaxant
(3.7%) or acetaminophen (1.9%). Compound cream alone and
opioids alone were reported to be most helpful for pain relief in
5.6% of the procedures.

Discussion
It’s a common belief of patients that the tissue expansion is a
daunting and painful procedure. However, findings from this
case series analysis show that, overall, patients were comfortable
with the tissue expansion process and experienced relatively low
anxiety and pain during and after the procedure. Patients experienced little to no pain (an average of 0.4-2.5 of 10 pain levels)
after each expansion, and the pain did not last, on average, longer
than 1 day. Majority of patients did not require any pain reduction. Of the different pain management modalities used, ibuprofen was the most common option and was reported to be the
most helpful in alleviating pain by patients.

To the best of our knowledge, this is the first study to report
pain levels during the tissue expansion process for breast reconstruction. Ibuprofen and other NSAIDs have been used successfully to relieve different types of breast pain.13-16 It has
been used to reduce pain in other situations by inhibiting
cyclooxygenase and the local inflammatory process.11 In addition to pain relief, ibuprofen is easily accessible over-thecounter and doesn’t cause addictive or adverse side effects like
that of opioids.15 However, if used in excess, ibuprofen can
cause renal impairment and peptic ulcer.17,18 If used appropriately, ibuprofen is both effective and safe to use. Other studies
have reported that acetaminophen is as effective as NSAIDs.11
Ice has been found in other instances to help alleviate pain
by decreasing nerve conduction, reducing muscle spasms, and
preventing edema.19 Muscle relaxants have been used to reduce
perioperative pain from breast augmentations.20 In other situations, topical anesthetics like compound creams and EMLA
have also been found to have some efficacy in pain management.12
Ice, ibuprofen, and EMLA are relatively inexpensive and
may be purchased over-the-counter, which is a clear advantage for patients.
One limitation to this study was the small sample size, which
restricted us from comparing the efficacy different pain management medications used during tissue expansion. We also didn’t
characterize the quality of pain that patients experienced. The
findings from this study need to be assessed through a prospective study with a larger sample size to confirm or refute these
results and preferably with a comparison group.

4

Cancer Control 24(4)

Figure 3. The most helpful pain management modalities for patients during the tissue expansion process.

The postmastectomy stage is a very difficult and vulnerable
time for many female patients. Since these patients already
encounter many psychological, emotional, sexual, physical,
and spiritual issues during their breast reconstruction process,
it is critical that we alleviate their concerns about pain associated with this procedure.11,21 Many patients come into the process with a preconceived notion that tissue expansion is a very
painful process. Our study demonstrated that tissue expansion
after mastectomy is a safe and mostly painless process and that
any discomfort that the patient may experience can be easily
treated with over-the-counter options like ibuprofen.
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